All Stories

  1. Effects of Sacubitril/Valsartan Versus Irbesartan in Patients with Chronic Kidney Disease: A Randomised Double-Blind Trial
  2. Meta-analysis
  3. Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy
  4. Impact of CKD on Household Income
  5. Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
  6. Confounding is not the only bias influencing associations of adiposity with cardiovascular disease
  7. Campath, calcineurin inhibitor reduction, and chronic allograft nephropathy (the 3C Study) - results of a randomized controlled clinical trial
  8. Biliary Tract and Liver Complications in Polycystic Kidney Disease
  9. Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection
  10. Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection
  11. Evidence for Reverse Causality in the Association Between Blood Pressure and Cardiovascular Risk in Patients With Chronic Kidney DiseaseNovelty and Significance
  12. Effect of Processing Delay and Storage Conditions on Urine Albumin-to-Creatinine Ratio
  13. Randomized multicentre pilot study of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: United Kingdom Heart and Renal Protection (HARP)- III—rationale, trial design and baseline data
  14. Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)
  15. Use of Causal Diagrams to Inform the Design and Interpretation of Observational Studies: An Example from the Study of Heart and Renal Protection (SHARP)
  16. Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies
  17. Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD
  18. The impact of social disadvantage in moderate-to-severe chronic kidney disease: an equity-focused systematic review
  19. Use of gel-based separator tubes to stabilise phosphate in mailed blood samples
  20. Is it time to increase access to transplantation for those with diabetic end-stage kidney disease?
  21. Dependent censoring in piecewise exponential survival models
  22. Evidence for the Prevention and Treatment of Stroke in Dialysis Patients
  23. Evaluating the Contribution of the Cause of Kidney Disease to Prognosis in CKD: Results From the Study of Heart and Renal Protection (SHARP)
  24. The Effect of Lowering LDL Cholesterol on Vascular Access Patency: Post Hoc Analysis of the Study of Heart and Renal Protection